Lipid nanoparticles for hepatic delivery of small interfering RNA.
about
Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.Selective targeting of alveolar type II respiratory epithelial cells by anti-surfactant protein-C antibody-conjugated lipoplexesEnhanced intrapulmonary delivery of anticancer siRNA for lung cancer therapy using cationic ethylphosphocholine-based nanolipoplexes.Comparative cellular pharmacokinetics and pharmacodynamics of siRNA delivery by SPANosomes and by cationic liposomesTargeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis.Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics.Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery.MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer.A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia.Synthesis and gene transfection activity of cyclen-based cationic lipids with asymmetric acyl-cholesteryl hydrophobic tails.Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs.Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulationsEvaluation of antitumor activity of survivin short interfering RNA delivered by lipid nanoparticles in colon cancer in vitro and in vivo.RNA Therapeutics in Oncology: Advances, Challenges, and Future Directions.Structure-delivery relationships of lysine-based gemini surfactants and their lipoplexes.
P2860
Q34446374-6892AC44-CF75-423C-96EC-26474EE51454Q35434883-B2EEF5AF-149F-4EDA-BE8C-C94B1ED8B91CQ36740249-287A4FCE-BC3B-4750-AE84-DE531E5F547FQ36788349-06FBB4FC-29D9-43B4-8DF3-1E8FF3996265Q37636279-EC0C6D15-C725-4840-BC82-38D54BFAA59BQ38802167-FA398527-132D-4C32-8AC3-B74C7B9E93F4Q38844509-A50DD579-71EE-4218-B869-DFE114944942Q38971815-0B5EF808-2FCB-41D3-9F2A-D564323D1043Q38977151-50321429-A33C-4790-A611-778F36F751BDQ39002262-6F62C27D-44FC-4EAA-895D-17834DF39E6BQ39003380-8FDA2BA0-8264-492A-A3A0-F86434D62086Q39080011-D3C91244-136F-4701-9BE8-F3FA284EE0D7Q41145076-2FD6109F-6F7C-4895-BCEE-6B84B02E57C4Q47786398-CB36B60B-360E-4B1D-8454-3276F6F70F4EQ50453864-74483926-EF27-4AAE-8C65-75EC65ED122C
P2860
Lipid nanoparticles for hepatic delivery of small interfering RNA.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Lipid nanoparticles for hepatic delivery of small interfering RNA.
@en
Lipid nanoparticles for hepatic delivery of small interfering RNA.
@nl
type
label
Lipid nanoparticles for hepatic delivery of small interfering RNA.
@en
Lipid nanoparticles for hepatic delivery of small interfering RNA.
@nl
prefLabel
Lipid nanoparticles for hepatic delivery of small interfering RNA.
@en
Lipid nanoparticles for hepatic delivery of small interfering RNA.
@nl
P2093
P2860
P1433
P1476
Lipid nanoparticles for hepatic delivery of small interfering RNA
@en
P2093
Chenguang Zhou
Kalpana Ghoshal
Megan C Terp
Robert J Lee
Samson T Jacob
Weiming Xue
Xinmei Wang
P2860
P304
P356
10.1016/J.BIOMATERIALS.2012.05.002
P577
2012-05-29T00:00:00Z